The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Jacobsen, L. K.
* Articles by Gelernter, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Jacobsen, L. K.
* Articles by Gelernter, J.
Related Collections
* Genetics
* SPECT
Am J Psychiatry 157:1700-1703, October 2000
© 2000 American Psychiatric Association

Brief Report

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

Leslie K. Jacobsen, M.D., Julie K. Staley, Ph.D., Sami S. Zoghbi, Ph.D., John P. Seibyl, M.D., Thomas R. Kosten, M.D., Robert B. Innis, M.D., Ph.D., and Joel Gelernter, M.D.

OBJECTIVE: Evidence of a relationship between genotype and binding availability was assessed for the dopamine and serotonin transporter genes. METHOD: The authors assessed dopamine transporter genotype at the SLC6A3 3' variable number of tandem repeats (VNTR) polymorphism and serotonin transporter genotype at the SLC6A4 promotor VNTR polymorphism in 30 healthy subjects who also underwent single photon emission computed tomography with [123I]ß-CIT. RESULTS: Subjects homozygous for the 10-repeat allele at the SLC6A3 locus demonstrated significantly lower dopamine transporter binding than carriers of the nine-repeat allele. There was no effect of SLC6A4 genotype upon serotonin transporter binding. CONCLUSIONS: These findings suggest that genetic variation at the SLC6A3 3' VNTR polymorphism may modify dopamine transporter function.




This article has been cited by other articles:


Home page
 Schizophr BullHome page
M. N. Bamne, M. E. Talkowski, K. V. Chowdari, and V. L. Nimgaonkar
Functional Analysis of Upstream Common Polymorphisms of the Dopamine Transporter Gene
Schizophr Bull, March 9, 2009; (2009) sbp005v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Bertolino, L. Fazio, A. Di Giorgio, G. Blasi, R. Romano, P. Taurisano, G. Caforio, L. Sinibaldi, G. Ursini, T. Popolizio, et al.
Genetically Determined Interaction between the Dopamine Transporter and the D2 Receptor on Prefronto-Striatal Activity and Volume in Humans
J. Neurosci., January 28, 2009; 29(4): 1224 - 1234.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-C. Dreher, P. Kohn, B. Kolachana, D. R. Weinberger, and K. F. Berman
Variation in dopamine genes influences responsivity of the human reward system
PNAS, January 13, 2009; 106(2): 617 - 622.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. M. van de Giessen, M. M.L. de Win, M. W.T. Tanck, W. van den Brink, F. Baas, and J. Booij
Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3
J. Nucl. Med., January 1, 2009; 50(1): 45 - 52.
[Abstract] [Full Text] [PDF]

Home page
 The ANNALS of the American Academy of Political and Social ScienceHome page
I. H. Carmen
Genetic Configurations of Political Phenomena: New Theories, New Methods
The ANNALS of the American Academy of Political and Social Science, November 1, 2007; 614(1): 34 - 55.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
M. Laucht, M. H. Skowronek, K. Becker, M. H. Schmidt, G. Esser, T. G. Schulze, and M. Rietschel
Interacting Effects of the Dopamine Transporter Gene and Psychosocial Adversity on Attention-Deficit/Hyperactivity Disorder Symptoms Among 15-Year-Olds From a High-Risk Community Sample
Arch Gen Psychiatry, May 1, 2007; 64(5): 585 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
T. Demiralp, C. S. Herrmann, M. E. Erdal, T. Ergenoglu, Y. H. Keskin, M. Ergen, and H. Beydagi
DRD4 and DAT1 Polymorphisms Modulate Human Gamma Band Responses
Cereb Cortex, May 1, 2007; 17(5): 1007 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
D. J. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, K. A. Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, et al.
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
J Psychopharmacol, January 1, 2007; 21(1): 10 - 41.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
S. N.P. Kelada, H. Checkoway, S. L.R. Kardia, C. S. Carlson, P. Costa-Mallen, D. L. Eaton, J. Firestone, K. M. Powers, P. D. Swanson, G. M. Franklin, et al.
5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study
Hum. Mol. Genet., October 15, 2006; 15(20): 3055 - 3062.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. L. Gilbert, Z. Wang, F. R. Sallee, K. R. Ridel, S. Merhar, J. Zhang, T. D. Lipps, C. White, N. Badreldin, and E. M. Wassermann
Dopamine transporter genotype influences the physiological response to medication in ADHD
Brain, August 1, 2006; 129(8): 2038 - 2046.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
A. L. Brody, M. A. Mandelkern, R. E. Olmstead, D. Scheibal, E. Hahn, S. Shiraga, E. Zamora-Paja, J. Farahi, S. Saxena, E. D. London, et al.
Gene Variants of Brain Dopamine Pathways and Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens.
Arch Gen Psychiatry, July 1, 2006; 63(7): 808 - 816.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
A. M. Lee and R. F. Tyndale
Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment
J Psychopharmacol, July 1, 2006; 20(4_suppl): 7 - 14.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
J. Audrain-McGovern, D. Rodriguez, E. P. Wileyto, K. H. Schmitz, and P. G. Shields
Effect of team sport participation on genetic predisposition to adolescent smoking progression.
Arch Gen Psychiatry, April 1, 2006; 63(4): 433 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. H. Schott, C. I. Seidenbecher, D. B. Fenker, C. J. Lauer, N. Bunzeck, H.-G. Bernstein, W. Tischmeyer, E. D. Gundelfinger, H.-J. Heinze, and E. Duzel
The Dopaminergic Midbrain Participates in Human Episodic Memory Formation: Evidence from Genetic Imaging
J. Neurosci., February 1, 2006; 26(5): 1407 - 1417.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. V. Parsey, R. S. Hastings, M. A. Oquendo, X. Hu, D. Goldman, Y.-y. Huang, N. Simpson, J. Arcement, Y. Huang, R. T. Ogden, et al.
Effect of a Triallelic Functional Polymorphism of the Serotonin-Transporter-Linked Promoter Region on Expression of Serotonin Transporter in the Human Brain
Am J Psychiatry, January 1, 2006; 163(1): 48 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
K.-J. Brookes, J. Mill, C. Guindalini, S. Curran, X. Xu, J. Knight, C.-K. Chen, Y.-S. Huang, V. Sethna, E. Taylor, et al.
A Common Haplotype of the Dopamine Transporter Gene Associated With Attention-Deficit/Hyperactivity Disorder and Interacting With Maternal Use of Alcohol During Pregnancy
Arch Gen Psychiatry, January 1, 2006; 63(1): 74 - 81.
[Abstract] [Full Text] [PDF]

Home page
 Behav Cogn Neurosci RevHome page
E. Congdon and T. Canli
The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches.
Behav Cogn Neurosci Rev, December 1, 2005; 4(4): 262 - 281.
[Abstract] [PDF]

Home page
 JNMHome page
C. H. van Dyck, R. T. Malison, L. K. Jacobsen, J. P. Seibyl, J. K. Staley, M. Laruelle, R. M. Baldwin, R. B. Innis, and J. Gelernter
Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene
J. Nucl. Med., May 1, 2005; 46(5): 745 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen
Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Pharmacol. Rev., March 1, 2005; 57(1): 1 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
S. Fuke, N. Sasagawa, and S. Ishiura
Identification and Characterization of the Hesr1/Hey1 as a Candidate trans-Acting Factor on Gene Expression through the 3' Non-Coding Polymorphic Region of the Human Dopamine Transporter (DAT1) Gene
J. Biochem., February 1, 2005; 137(2): 205 - 216.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. H Epstein, S. M Wright, R. A Paluch, J. J Leddy, L. W Hawk Jr, J. L Jaroni, F. G Saad, S. Crystal-Mansour, P. G Shields, and C. Lerman
Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 82 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
C. H. van Dyck, R. T. Malison, J. K. Staley, L. K. Jacobsen, J. P. Seibyl, M. Laruelle, R. M. Baldwin, R. B. Innis, and J. Gelernter
Central Serotonin Transporter Availability Measured With [123I]{beta}-CIT SPECT in Relation to Serotonin Transporter Genotype
Am J Psychiatry, March 1, 2004; 161(3): 525 - 531.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. Kaiser, A. Hofer, A. Grapengiesser, T. Gasser, A. Kupsch, I. Roots, and J. Brockmoller
L -Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
Neurology, June 10, 2003; 60(11): 1750 - 1755.
[Abstract] [Full Text] [PDF]


Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org